Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹960.7 Cr -0.6% -7% -40.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-0.6%

-7%

-40.2%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses